Instructions TF104K
Instructions TF104KS
Description
Transfection, the introduction of nucleic acid into mammalian cells, is a powerful technique used to study in vivo gene function and regulation. The Cytofect™ Cell Line Transfection kit is a plasmid DNA delivery system specifically optimized to deliver DNA into a wide variety of cell lines. This kit contains Cytofect™ 2 and Media for transfection and culturing cells. The result has been high transfection efficiency and viability for cell lines.
#Wells / Rxns
96 / 1000
24 / 250
12 / 125
The Kit contains all necessary reagents, media and optimized protocols to carry out successful transfection of cell lines with high efficiency (40%-90%) and viability (80%-95%), such as CHO, HEK293, HeLa and MCF7.
Products are for research use only. They are not intended for human, animal, or diagnostic applications. TR1 and PE are manufactured by Targeting Systems.
Details
Kit Contents: | Cytofect-2 Antibiotics-Free Growth Medium Transfection Medium |
Designed to improve transfection efficiency and cell viability, Cytofect is a plasmid DNA delivery system containing Cytofect-2, Enhancer and Media for transfecting and culturing cells. The Enhancer is an endosomolytic peptide that complexes with DNA and Cytofect-2, then escorts the transfection complex to the nucleus. The results are high transfection efficiency and viability for traditionally hard-to-transfect cells.
Products
Product | Size | CAT.# | Price | Quantity |
---|---|---|---|---|
Cytofect Cell Line Transfection Kit (250 x 24-Wells): 250 x 24-Well Rxns | Size: 1 Kit | CAT.#: TF104K | Price: $320.00 | |
Cytofect Cell Line Transfection Sample Kit (25 x 24-Wells): 25 x 24-Well Rxns | Size: 1 Sample Kit | CAT.#: TF104KS | Price: $68.00 |
Related Products
Product | Size | CAT.# | Price | Quantity |
---|---|---|---|---|
Cytofect-1 (CF1): Store at -20°C | Size: 250 ul | CAT.#: 051-250 | Price: $193.00 | |
Cytofect-1 (CF1): Store at -20°C | Size: 500 ul | CAT.#: 051-500 | Price: $311.00 | |
Cytofect-2 (CF2) : Store at 4°C | Size: 250 ul | CAT.#: 052-250 | Price: $193.00 | |
Cytofect-2 (CF2) : Store at 4°C | Size: 500 ul | CAT.#: 052-500 | Price: $311.00 | |
Peptide Enhancer (PE): Store at 4°C | Size: 250 ul | CAT.#: 053-250 | Price: $155.00 | |
Peptide Enhancer (PE): Store at 4°C | Size: 500 ul | CAT.#: 053-500 | Price: $260.00 | |
Viral Enhancer (VE): Store at -20°C | Size: 250 ul | CAT.#: 054-250 | Price: $155.00 | |
Viral Enhancer (VE): Store at -20°C | Size: 500 ul | CAT.#: 054-500 | Price: $260.00 | |
Cyyofect Transfection Medium: Cyyofect Transfection Medium | Size: 500 ml | CAT.#: TF56-500 | Price: $54.00 |
Resources/Documents
Citations
Publications
2016
Sahoo, S., D. Meijles, I. Ghouleh, M. Tandon, E. Cifuentes-Pagano, J. Sembrat, M. Rojas, E. Goncharova and P. Pagano. 2016. MEF2C-MYOCD and Leiomodin1 Suppression by miRNA-214 Promotes Smooth Muscle Cell Phenotype Switching in Pulmonary Arterial Hypertension. PLoS ONE, dx.doi.org/10.1371/journal.pone.0153780.
2015
Dokun, A., L. Chen, M. Okutsu, C. Farber, S. Hazarika, W. Jones, D. Craig, D. Marchuk, J. Lye, S. Shan, and B. Annex. 2015. ADAM12: A Genetic Modifier of Pre-clinical Peripheral Arterial Disease. Am J Physiol, DOI: 10.1152/ajpheart.00803.2014.
Zelko, I., and R. Folz. 2015. Regulation of Oxidative Stress in Pulmonary Artery Endothelium: Modulation of EC-SOD and NOX4 Expression Using HDAC Class I Inhibitors. Am J Respir Cell Mol Biol, DOI: 10.1165/rcmb.2014-0260OC.
2013
Chen, Z., T.C. Lai, Y.H. Jan, F.M. Lin, W.C. Wang, H. Xiao, Y.T. Wang, W. Sun, X. Cui, Y.S. Li, T. Fang, H. Zhao, C. Padmanabhan, R. Sun, D.L. Wang, H. Jin, G.Y. Chau, H.D. Huang, M. Hsiao, and J.Y.J. Shyy. 2013. Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis. The Journal of Clinical Investigation. 123:1057-1067.
He, M., X. Liang, L. He, W. Wen, S. Zhao, L. Wen, Y. Liu, J.Y.J. Shyy, and Z. Yuan. 2013. Endothelial dysfunction in rheumatoid arthritis: the role of monocyte chemotactic protein-1-induced protein. Arteriosclerosis, Thrombosis, and Vascular Biology. 33:1384-1391.
Yan, Y., X. Li, K. Kover, M. Clements, and P. Ye. 2013. CREB participates in the IGF‐I‐stimulation cyclin D1 transcription. Developmental Neurobiology. 73:559-570.
2012
Jeon, Y.J., M.G. Jo, H.M. Yoo, S.H. Hong, J.M. Park, S.H. Ka, K.H. Oh, J.H. Seol, Y.K. Jung, and C.H. Chung. 2012. Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. The Journal of Clinical Investigation. 122:2622-2636.